sec filing
FU
NASDAQ · FULC
Fulcrum Therapeutics, Inc.
Healthcare · Biotechnology
$3.71
Up+$0.03 (+0.81%)
Updated Aug 14, 2026, 9:06 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 692.63M
- P/E ratio
- -11.27
- Dividend yield
- 0.00%
- 52-week range
- $2.83 – $8.37
- Volume
- 1.36M
- Avg. volume
- 1.17M
Price performance
FULC price history
1M range · 21 trading sessions · Daily adjusted prices
FULC closed at $3.71 after 21 trading sessions, up 6.00% for the selected period.
- Last close
- $3.71
- Period change
- +6.00%
- Period low
- $3.50
- Period high
- $3.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $3.75 | $3.76 | $3.64 | $3.71 | 1.36M |
| Aug 12, 2026 | $3.70 | $3.74 | $3.615 | $3.72 | 901.4K |
| Aug 11, 2026 | $3.77 | $3.775 | $3.655 | $3.69 | 804.12K |
| Aug 10, 2026 | $3.85 | $3.87 | $3.74 | $3.75 | 1.12M |
| Aug 7, 2026 | $3.83 | $3.91 | $3.77 | $3.89 | 1.46M |
| Aug 6, 2026 | $3.76 | $3.815 | $3.685 | $3.77 | 1.04M |
| Aug 5, 2026 | $3.80 | $3.82 | $3.72 | $3.77 | 1.25M |
| Aug 4, 2026 | $3.73 | $3.835 | $3.695 | $3.80 | 2.35M |
| Aug 3, 2026 | $3.63 | $3.725 | $3.544 | $3.71 | 2.26M |
| Jul 31, 2026 | $3.72 | $3.73 | $3.47 | $3.58 | 3.53M |
| Jul 30, 2026 | $3.60 | $3.75 | $3.58 | $3.72 | 1.15M |
| Jul 29, 2026 | $3.69 | $3.76 | $3.59 | $3.62 | 1.11M |
| Jul 28, 2026 | $3.73 | $3.76 | $3.62 | $3.72 | 1.2M |
| Jul 27, 2026 | $3.76 | $3.81 | $3.70 | $3.73 | 589.76K |
| Jul 24, 2026 | $3.78 | $3.81 | $3.70 | $3.72 | 572.86K |
| Jul 23, 2026 | $3.64 | $3.78 | $3.625 | $3.76 | 830.09K |
| Jul 22, 2026 | $3.69 | $3.735 | $3.61 | $3.70 | 1.42M |
| Jul 21, 2026 | $3.62 | $3.745 | $3.62 | $3.68 | 1.53M |
| Jul 20, 2026 | $3.71 | $3.775 | $3.58 | $3.62 | 822.2K |
| Jul 17, 2026 | $3.47 | $3.785 | $3.46 | $3.65 | 2.3M |
| Jul 16, 2026 | $3.77 | $3.7759 | $3.45 | $3.50 | 2.72M |
Latest FULC news
The latest Smart Investors Daily articles mentioning FULC.
Stock researchResearch & News · Analysis
Loading stock research…

